Search results
Results from the WOW.Com Content Network
The North Carolina Biotechnology Center is a non-profit, public-private partnership organization located in Research Triangle Park (North Carolina, United States).Founded in 1984 by the North Carolina General Assembly, it was the first state-sponsored biotechnology initiative in the United States, merging the interests of the academic private and public sectors. [1]
United Therapeutics Corporation is an American publicly traded biotechnology company [2] and public benefit corporation [3] listed on the NASDAQ under the symbol UTHR. [4] [5] It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing.
Syneos Health (formerly InVentiv Health Incorporated and INC Research) is an American company that provides contract research and commercial services to pharmaceutical and biotechnology companies. Based in Morrisville, North Carolina , the company specializes in helping other companies with late-stage clinical trials, but also provides ...
Johnson & Johnson, Janseen’s parent company, agreed to invest $1 billion at the site by the end of 2028 — though the corporation says it will exceed its state incentive deal and ultimately ...
According to the North Carolina Biotechnology Center, North Carolina is home to 528 biotechnology companies that provide 57,000 jobs and $1.92 billion in taxes for state and local government. [3] Employment in the industry has grown 4.1% from 2008 to 2010, when other industries shed thousands of jobs. [ 4 ]
The company offered clinical data management, clinical trial execution services, pharmaceuticals, drug development, financial partnering, and commercialization expertise to companies in the biotechnology, pharmaceutical and healthcare sectors. In 1982, Dennis Gillings founded and incorporated Quintiles Transnational in North Carolina. [19]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
A biologics license application (BLA) is defined by the U.S. Food and Drug Administration (FDA) as follows: The biologics license application is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce (21 CFR 601.2). The BLA is regulated under 21 CFR 600 – 680.